Simultaneous determination of piroxicam and its major metabolite 5′-hydroxypiroxicam in human plasma by derivative spectrophotometry

(Note: The full text of this document is currently only available in the PDF Version )

Vicente Ródenas


Abstract

A first-derivative spectrophotometric method for the simultaneous determination of piroxicam (PX) and its major metabolite 5′-hydroxypiroxicam (OH PX) in human plasma is described. The method consists of direct extraction of the two drugs from the plasma samples with hydrochloric and trichloroacetic acid prior to their determination by measuring the first-derivative signals at 337.0 nm for PX and at 327.0 nm for OHPX (zero-crossing wavelength). The calibration graphs were linear up to 10.0 and 8.0 mg l–1 of PX and OH PX, respectively, and the limits of quantification were 0.27 and 0.56 mg l–1. The possible interfering effects of other substances were studied.


References

  1. A. Goodman, L. S. Goodman, T. W. Rall and F. Murad, Las Bases Farmacológicas de la Terapeútica, 7th edn., Panamericana, Madrid, 1989, p. 669 Search PubMed.
  2. K. Olkkola, A. Brunetto and M. Mattila, Clin. Pharmacokinet, 1994, 26, 107 Search PubMed.
  3. T. Ishizaki, T. Nomura and T. Abe, J. Pharmacokin. Biopharm., 1979, 7, 369 Search PubMed.
  4. D. Hobbs and T. Twomey, J. Clin. Pharmacol., 1979, 19, 270 Search PubMed.
  5. H. Julkumen, J. Michelson and M. Mattila, Ann. Clin. Res., 1983, 15, 99 Search PubMed.
  6. T. M. Twomey, S. R. Bartolucci and D. C. Hobbs, J. Chromatogr., 1980, 183, 104 CrossRef.
  7. C. J. Richardson, S. G. Ross, K. L. Blockc and R. K. Werbeeck, J. Chromatogr., 1986, 382, 382 CAS.
  8. K. D. Riedel and H. Laufen, J. Chromatogr., 1988, 276, 243.
  9. J. S. Dixon, J. R. Lowe and D. B. Galloway, J. Chromatogr., 1984, 310, 455 CrossRef CAS.
  10. P. J. Street, J. Chromatogr., 1989, 495, 179.
  11. A. G. Kazemifard and D. E. Moore, J. Chromatogr., 1990, 533, 125 CrossRef.
  12. T. Suwa, H. Urano, U. Shimohara and J. Kokatsu, J. Chromatogr., 1993, 617, 105 CrossRef CAS.
  13. A. Avgerinos, S. Axarlis, J. Dragatsis, T. Karidas and S. Malamataris, J. Chromatogr., 1995, 673, 142 CrossRef CAS.
  14. M. T. Maya, J. P. Pais and J. A. Morais, J. Pharm. Biomed. Anal., 1998, 13, 319 CrossRef CAS.
  15. T. C. O'Haver, Clin. Chem., 1979, 25, 1548 CAS.
  16. A. G. Davidson, J. Pharm. Biomed. Anal., 1985, 3, 329 CrossRef CAS.
  17. P. Levillain and D. Fompeydie, Analusis, 1986, 14, 1 CAS.
  18. F. Sanchez Rojas, C. Bosch Ojeda and J. M. Cano Pavon, Talanta, 1988, 35, 753 CrossRef.
  19. M. Knocken and I. Dol, Analyst, 1992, 117, 1385 RSC.
  20. A. F. Fell, D. R. Jarvie and M. J. Steward, Clin. Chem., 1981, 27, 286 CAS.
  21. M. Domingo and M. P. Gimenez, J. Anal. Toxicol., 1981, 5, 10.
  22. M. Parissi-Poulou and P. Macheras, Int. J. Pharm., 1986, 3, 29.
  23. F. Salinas, J. J. Berzas-Nevado and A. Espinosa, Analyst, 1989, 114, 1141 RSC.
  24. J. M. Garcia-Fraga, A. I. Jimenez-Abizanda, F. Jimenez-Moreno and J. J. Arias-Leon, J. Pharm. Biomed. Anal., 1991, 9, 109 CrossRef CAS.
  25. G. Carlucci, P. Mazzeo and M. Bologna, J. Pharm. Biomed. Anal., 1991, 9, 1169 CrossRef CAS.
  26. B. Morelli, Analyst, 1988, 113, 1077 RSC.
  27. M. Parissi-Poulou, V. Reizopoulou, M. Koupparis and P. Macheras, Int. J. Pharm., 1989, 51, 169 CrossRef CAS.
  28. B. Morelli, Analyst, 1900, 79, 261 Search PubMed.
  29. I. Panderi and M. Parissi-Poulou, Int. J. Pharm., 1992, 86, 99 CrossRef CAS.
  30. A. F. M. El Walily, F. El-Anwar, M. A. Eid and H. Awaad, Analyst, 1992, 117, 981 RSC.
  31. B. Morelli, Anal. Lett., 1998, 21, 43.
  32. G. L. Long and J. D. Winefordner, Anal. Chem., 1983, 55, 712A CrossRef CAS.
Click here to see how this site uses Cookies. View our privacy policy here.